Study type

Study topic

Human medicinal product
Disease /health condition

Study type

Non-interventional study

Scope of the study

Assessment of risk minimisation measure implementation or effectiveness
Disease epidemiology
Drug utilisation

Data collection methods

Secondary use of data
Non-interventional study

Non-interventional study design

Cohort
Other

Non-interventional study design, other

Descriptive
Study drug and medical condition

Anatomical Therapeutic Chemical (ATC) code

(N06BA04) methylphenidate
methylphenidate
(N06BA02) dexamfetamine
dexamfetamine
(N06BA09) atomoxetine
atomoxetine

Medical condition to be studied

Attention deficit hyperactivity disorder
Population studied

Short description of the study population

The study cohort will include children and adolescents (hereafter referred to as children) ≤ 24 years old who use attention deficit hyperactivity disorder (ADHD) medication for the first time (incident users).

Age groups

Children (2 to < 12 years)
Adolescents (12 to < 18 years)
Adults (18 to < 46 years)

Estimated number of subjects

20000
Study design details

Main study objective

Is there a relationship between the month of birth and the pharmacological treatment of ADHD in children and adolescents?

Outcomes

The start of ADHD medication.

Data analysis plan

The analysis will be descriptive. The children receiving ADHD medication with a different month of birth will be compared. The age at which a child receives the treatment for the first time will be defined, it will be represented as the number of months from birth until the first dispensing date. Also the period the children use the ADHD medication will be analysed. The measures of occurrence and association are the incidence rates and the relative risks.Analyses are stratified according to sex, age categories and the calendar year the ADHD medication is dispensed for the first time. We will correct for the total number of births in different months/years.